Compare metabolites in 2 of these studies:
Study A:   Study B:  

List of Studies ( Metabolite:1-DeoxyCer 18:1;O/26:1)

Study_idAnalysis_idStudy_titleSourceSpeciesDiseaseInstituteUnits(range)
ST000916 AN001495 Biomarkers of NAFLD progression: a lipidomics approach to an epidemic. Part 2:Plasma Blood Human Fatty liver disease LIPID MAPS nM
ST000917 AN001501 Biomarkers of NAFLD progression: a lipidomics approach to an epidemic. Part 3:Urine Urine Human Fatty liver disease LIPID MAPS nM
ST002284 AN003732 Genetically defined human GBM organoids reveal principles of GBM development and actionable targets Cultured cells Human Cancer DKFZ peak intensity
ST000915 AN001489 Biomarkers of NAFLD progression: a lipidomics approach to an epidemic. Part 2:Liver Liver Human Fatty liver disease LIPID MAPS pmol/mg
  logo